VICTORIA HOHMANN: Open Payments
NPI 1154042547 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 9 payments from 6 companies in 2025. Trend: 2023 $2,147 · 2024 $272 · 2025 $464
Food & beverage: $253Education: $210
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $242 |
| Lilly USA, LLC | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Gilead Sciences, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $17 |
Products named: RYBREVANT, DARZALEX, Trodelvy, SCEMBLIX, Fabhalta, OJJAARA, NERLYNX.
Industry payments across NY — which companies pay providers there.
